Nurix Therapeutics, Inc. · NASDAQ:NRIX
Ring Christine sold 3,847 Nurix Therapeutics, Inc. shares (Form 4)
Traded Jul 30, 2026 · Filed Jul 30, 2026
On Jul 30, 2026, Ring Christine (Chief Legal Officer) sold 3,847 Nurix Therapeutics, Inc. shares at US$23.38 for US$89,943, leaving 19,912 shares. Filed Jul 30, 2026 (Form 4).
- Sold
- 3,847 shares
- Price
- US$23.38
- Value
- US$89,943
- Holding after
- 19,912 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | Option exercise | 3,750 | 17,329 | Direct | |
| Jul 30, 2026 | Common Stock | Option exercise | 2,858 | 20,187 | Direct | |
| Jul 30, 2026 | Common Stock | Option exercise | 3,572 | 23,759 | Direct | |
| Jul 30, 2026 | Common Stock | Sale | 3,847 | US$23.38 | 19,912 | Direct |
Source
Related
- Nurix Therapeutics, Inc.
- Ring Christine
- Nurix Therapeutics, Inc. shareholders
- Form 4 · Ring Christine · Oct 2, 2026
- Form 4 · Ring Christine · Sep 2, 2026
- Form 4 · Ring Christine · Aug 3, 2026
- Form 4 · Ring Christine · Jul 2, 2026
- Form 4 · Ring Christine · Jun 25, 2026
- Form 4 · Hansen Gwenn · Oct 15, 2026
- Form 4 · Gregory Julia P · Oct 14, 2026
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Form 4 · Hansen Gwenn · Sep 1, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026